Central Texas Spine Institute, Northwest Hills Surgical Hospital — Austin, Texas

Central Texas Spine Institute, Northwest Hills Surgical Hospital is a clinical research site located in Austin, Texas, United States 78731.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Central Texas Spine Institute, Northwest Hills Surgical Hospital has participated in 1 clinical trials.

Therapeutic areas: Degenerative Disc Disease, Lumbar.

Sponsors: NuVasive.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Austin

Browse all research sites in Texas · View every site in Austin

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Texas Spine Institute, Northwest Hills Surgical Hospital?

Central Texas Spine Institute, Northwest Hills Surgical Hospital has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Texas Spine Institute, Northwest Hills Surgical Hospital conducted?

Central Texas Spine Institute, Northwest Hills Surgical Hospital has 1 clinical trials on record. Their work covers Degenerative Disc Disease, Lumbar.

Is Central Texas Spine Institute, Northwest Hills Surgical Hospital accredited by Crixeo Clinical Trials?

Central Texas Spine Institute, Northwest Hills Surgical Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Texas Spine Institute, Northwest Hills Surgical Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.